Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Study of ASCT for #POEMS syndrome finds heme response to 1st-line therapy in 77.5%, median PFS 102.6 months and OS 146.9 months, 5-year rates of 69.0% and 87.6%; baseline ECOG and depth of heme response correlated with outcomes.”
Title: Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes
Authors: Luis Gerardo Rodríguez-Lobato, Anna de Daniel, Itziar Carro Arostegui, Iago Arribas Castro, Mercedes Gironella, Jordi Verge, Lourdes Escoda, Carles Tolosa, Josep María Martí-Tutusaus, Cristina Baca, Eugènia Abella, Cristina Motlló, Jordi López-Pardo, Albert Oriol, Carlos Castillo-Girón, Natalia Tovar, Laura Rosiñol, M. Teresa Cibeira, Anna Sureda, Carlos Fernández de Larrea
You can read the Full Article on Bone Marrow Transplantation.
You can find other articles featuring Robert Orlowski on OncoDaily.
